<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04399707</url>
  </required_header>
  <id_info>
    <org_study_id>2019-035</org_study_id>
    <nct_id>NCT04399707</nct_id>
  </id_info>
  <brief_title>Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control</brief_title>
  <official_title>Transcutaneous Electrical Nerve Stimulation for Post-Cesarean Pain Control</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hawaii Pacific Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hawaii Pacific Health</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose of study is to evaluate the efficacy of transcutaneous electrical nerve stimulation
      (TENS) for post-operative pain control after a cesarean delivery compared to placebo and no
      TENS.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 29, 2020</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants are randomized to one of three groups in parallel for the duration of the study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative narcotic consumption</measure>
    <time_frame>First 60 hours post-operatively</time_frame>
    <description>Total postoperative narcotic consumption (measured in morphine equivalents)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of hospitalization</measure>
    <time_frame>From date of cesarean delivery until discharge from hospital, assessed up to 1 month</time_frame>
    <description>Length of stay in hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain assessed by numeric analog scale (NAS) (0-10; 0: no pain at all, 10: worst imaginable pain)</measure>
    <time_frame>On post-operative days 1, 2, 3, and day of discharge, assessed up to 1 month</time_frame>
    <description>Pain scoring</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with pain control assessed by NAS (0-10; 0: very dissatisfied, 10: very satisfied)</measure>
    <time_frame>On post-operative days 1, 2, 3, and day of discharge, assessed up to 1 month</time_frame>
    <description>Pain control satisfaction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse reactions to TENS unit</measure>
    <time_frame>From date of randomization until date of discharge, assessed up to 1 month</time_frame>
    <description>Adverse reactions to TENS unit</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Transcutaneous Electric Nerve Stimulation</condition>
  <condition>Analgesia</condition>
  <condition>Cesarean Section</condition>
  <arm_group>
    <arm_group_label>Active TENS Unit</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo TENS Unit</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>No TENS Unit</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous electrical nerve stimulation (TENS) unit</intervention_name>
    <description>Patients will be randomized to active TENS unit, placebo TENS unit, or no TENS unit</description>
    <arm_group_label>Active TENS Unit</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo transcutaneous electrical nerve stimulation (TENS) unit</intervention_name>
    <description>Patients will be randomized to active TENS unit, placebo TENS unit, or no TENS unit</description>
    <arm_group_label>Placebo TENS Unit</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Women undergoing scheduled or non-urgent cesarean section

        Exclusion Criteria:

          -  Non-English speaking

          -  Subjects with a history of chronic pain or chronic opioid use

          -  Pre-operative use of opioids for more than 1 week in the preceding 6 months

          -  Previous exposure to the TENS unit

          -  Women with an allergy or contraindication to narcotics/NSAIDs/acetaminophen

          -  Subjects who had a midline vertical skin incision during this operation

          -  Subjects who did not receive intrathecal opioids at the time of their cesarean
             delivery

          -  Adhesive allergies

          -  Subjects with a pacemaker (due to the unknown effects of the TENS on the electrical
             activity of the heart)

          -  Intraoperative general anesthesia

          -  Inability to consent to the study

          -  Postpartum tubal ligation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kelly Yamasato</last_name>
    <role>Principal Investigator</role>
    <affiliation>Physician</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nicole Kurata</last_name>
    <phone>(808)577-3344</phone>
    <email>nkurata@hawaii.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kelly Yamasato</last_name>
    <email>kyamasat@hawaii.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nicole Kurata</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96826</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Kurata</last_name>
      <phone>808-577-3344</phone>
      <email>nkurata@hawaii.edu</email>
    </contact>
    <investigator>
      <last_name>Kelly Yamasato, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicole Kurata, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bliss Kaneshiro, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Reema Ghatnekar, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.cdc.gov/vitalsigns/opioid-prescribing</url>
    <description>Related Info</description>
  </link>
  <reference>
    <citation>Bateman BT, Franklin JM, Bykov K, Avorn J, Shrank WH, Brennan TA, Landon JE, Rathmell JP, Huybrechts KF, Fischer MA, Choudhry NK. Persistent opioid use following cesarean delivery: patterns and predictors among opioid-na√Øve women. Am J Obstet Gynecol. 2016 Sep;215(3):353.e1-353.e18. doi: 10.1016/j.ajog.2016.03.016. Epub 2016 Mar 17.</citation>
    <PMID>26996986</PMID>
  </reference>
  <reference>
    <citation>Desantana JM, Sluka KA, Lauretti GR. High and low frequency TENS reduce postoperative pain intensity after laparoscopic tubal ligation: a randomized controlled trial. Clin J Pain. 2009 Jan;25(1):12-9. doi: 10.1097/AJP.0b013e31817d1070.</citation>
    <PMID>19158541</PMID>
  </reference>
  <reference>
    <citation>Bjordal JM, Johnson MI, Ljunggreen AE. Transcutaneous electrical nerve stimulation (TENS) can reduce postoperative analgesic consumption. A meta-analysis with assessment of optimal treatment parameters for postoperative pain. Eur J Pain. 2003;7(2):181-8.</citation>
    <PMID>12600800</PMID>
  </reference>
  <reference>
    <citation>Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, Carter T, Cassidy CL, Chittenden EH, Degenhardt E, Griffith S, Manworren R, McCarberg B, Montgomery R, Murphy J, Perkal MF, Suresh S, Sluka K, Strassels S, Thirlby R, Viscusi E, Walco GA, Warner L, Weisman SJ, Wu CL. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016 Feb;17(2):131-57. doi: 10.1016/j.jpain.2015.12.008. Erratum in: J Pain. 2016 Apr;17(4):508-10. Dosage error in article text.</citation>
    <PMID>26827847</PMID>
  </reference>
  <reference>
    <citation>Dowswell T, Bedwell C, Lavender T, Neilson JP. Transcutaneous electrical nerve stimulation (TENS) for pain relief in labour. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD007214. doi: 10.1002/14651858.CD007214.pub2. Review.</citation>
    <PMID>19370680</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>February 18, 2020</study_first_submitted>
  <study_first_submitted_qc>May 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2020</study_first_posted>
  <last_update_submitted>May 21, 2020</last_update_submitted>
  <last_update_submitted_qc>May 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hawaii Pacific Health</investigator_affiliation>
    <investigator_full_name>Kelly Yamasato, MD</investigator_full_name>
    <investigator_title>Physician, Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>TENS</keyword>
  <keyword>Transcutaneous electric nerve stimulation</keyword>
  <keyword>Cesarean analgesia</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

